Shelter Pharma Limited has informed the stock exchanges that its board of directors will meet on Thursday, May 28, 2026. The meeting is convened to consider, approve, and take on record the audited financial results for the half year and year ended March 31, 2026.

The board will review the financial performance in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will also cover any other business that may be considered necessary with the permission of the chair.

The gathering is set to take place at 5th Floor, 501 SAKAR 4, Opp. MJ Library Ashram Road Paldi, Ellisbridge, Ahmedabad, Gujarat -380006. The intimation was signed by Managing Director Mustaqim Nisarahmed Sabugar on May 22, 2026.

Meeting Details

Financial Periods Under Review

The board will specifically deliberate upon the financial statements for two distinct periods concluding on March 31, 2026. This includes the results for the half-year period as well as the full fiscal year.

Shelter Pharma Ltd has announced its participation in the 12th Edition of iPHEX 2026, one of India's leading international pharmaceutical and healthcare exhibitions. The event is scheduled to take place from September 7, 2026, to September 9, 2026, at Bharat Mandapam. The exhibition is organized by the Pharmaceuticals Export Promotion Council of India with the support of the Department of Commerce, Government of India.

The company has secured an exhibition stall to showcase its pharmaceutical and healthcare product portfolio. The target audience includes domestic and international business delegates, distributors, importers, and other industry participants. This strategic move is intended to enhance the company's global visibility and brand recognition.

Strategic Objectives

Participation in iPHEX 2026 is expected to yield several strategic benefits for the company:

• Strengthen relationships with existing customers and business associates
• Explore new export opportunities and international market expansion
• Facilitate B2B interactions with overseas buyers and healthcare stakeholders

The management believes that engaging in such globally recognized industry exhibitions aligns with Shelter Pharma's long-term growth and business development strategy.

Event Details